Longitude Capital Partners V, LLC

13D and 13G Filings

13D/G filings: 13D on 2 securities, 13G on 2 securities
CIK: 0002018312
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Entera Bio Ltd. 13G ENTX · M40527109	ENTX	M40527109	4.6%	7,843,138	13G	8/4/2026 Event 7/28/2026
Longitude Capital Partners V, LLC			4.6%	7,843,138
Longitude Venture Partners V, L.P.			4.6%	7,843,138
Patrick G. Enright			4.6%	7,843,138
Juliet Tammenoms Bakker			4.6%	7,843,138
CytomX Therapeutics, Inc. 13G/A Amendment 1 CTMX · 23284F105	CTMX	23284F105	7.0%	15,288,461	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Longitude Capital Partners V, LLC			5.7%	12,458,461
Longitude Venture Partners V, L.P.			5.7%	12,458,461
Longitude 103.8 East Partners, LLC			1.3%	2,830,000
Longitude 103.8 East, L.P.			1.3%	2,830,000
Patrick G. Enright			7.0%	15,288,461
Juliet Tammenoms Bakker			7.0%	15,288,461
Mobia Medical, Inc. 13D MOBI · 83084G109	MOBI	83084G109	9.8%	3,255,226	13D	5/13/2026 Event 5/11/2026
Longitude Capital Partners V, LLC			6.3%	2,088,560
Longitude Venture Partners V, L.P.			6.3%	2,088,560
Longitude 103.8 East Partners, LLC			3.5%	1,166,666
Longitude 103.8 East, L.P.			3.5%	1,166,666
Patrick G. Enright			9.8%	3,255,226
Juliet Tammenoms Bakker			9.8%	3,255,226
Veradermics, Incorporated 13D/A Amendment 1 MANE · 922967104	MANE	922967104	11.3%	4,653,873	13D/A Amendment 1	5/5/2026 Event 5/1/2026
Longitude Capital Partners V, LLC			6.3%	2,600,399
Longitude Venture Partners V, L.P.			6.3%	2,600,399
Longitude 103.8 East Partners, LLC			5.0%	2,053,474
Longitude 103.8 East, L.P.			5.0%	2,053,474
Patrick G. Enright			11.3%	4,653,873
Juliet Tammenoms Bakker			11.3%	4,653,873
Veradermics, Incorporated 13D MANE · 922967104	MANE	922967104	12.5%	4,653,873	13D	2/12/2026 Event 2/5/2026
Longitude Capital Partners V, LLC			7.0%	2,600,399
Longitude Venture Partners V, L.P.			7.0%	2,600,399
Longitude 103.8 East Partners, LLC			5.5%	2,053,474
Longitude 103.8 East, L.P.			5.5%	2,053,474
Patrick G. Enright			12.5%	4,653,873
Juliet Tammenoms Bakker			12.5%	4,653,873
CytomX Therapeutics, Inc. 13G CTMX · 23284F105	CTMX	23284F105	7.3%	11,538,461	13G	5/20/2025 Event 5/13/2025
Longitude Capital Partners V, LLC			7.3%	11,538,461
Longitude Venture Partners V, L.P.			7.3%	11,538,461
Patrick G. Enright			7.3%	11,538,461
Juliet Tammenoms Bakker			7.3%	11,538,461

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.